Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.128NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.451NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.313NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.402NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.609NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.344NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.556NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.245NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.403NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.636NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.126NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQ.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.31.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.8.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ED.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BU.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BG.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.576NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.325NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.521NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.378NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.206NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.57NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EF.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used